Our testing platform aims to integrate earlier cancer detection into routine medical care to empower longer, happier lives. Learn about our blood test, CancerSEEK.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $367M
Founded date: 2019
Investors 6
| Date | Name | Website |
| - | S32 | s32.com |
| 30.07.2020 | Lux Capita... | luxcapital... |
| 11.03.2021 | Section 32 | section32.... |
| - | Perceptive... | perceptive... |
| - | Catalio Ca... | cataliocap... |
| - | Blue Ventu... | blueventur... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.07.2020 | Series B | $257M | - |
| 30.05.2019 | Series A | $110M | - |
Mentions in press and media 13
| Date | Title | Description |
| 31.08.2021 | Liquid biopsy: misplaced faith in early cancer detection? | The trial of Theranos CEO Elizabeth Holmes for defrauding investors about the company’s blood tests highlights a more general reality: huge sums of money are being devoted to develop and promote diagnostic technologies with little evidence ... |
| 27.10.2020 | Hopkins-founded Thrive Earlier Detection acquired in $2.15B deal | Thrive Earlier Detection, a company that spun out of Johns Hopkins to commercialize a blood test for cancer, is set to be acquired by molecular diagnostics company Exact Sciences. The cash and stock deal could be worth up to $2.15 billion, ... |
| 30.07.2020 | Thrive Earlier Detection snags $257M for biopsy testing | Thrive Earlier Detection has raised $257 million in a Series B led by Casdin Capital and Section 32. Other investors including Bain Capital, Janus Henderson, T. Rowe Price and Lux Capital also supported the round. The funds will help advanc... |
| 29.07.2020 | Thrive Earlier Detection Closes $257 Million Series B Financing | Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care, today announced that it has raised $257 million in a Series B financing. The round was le... |
| 29.07.2020 | Hopkins-born Thrive Earlier Detection Corp. raises $257M to further cancer blood test development | Thrive Earlier Detection Corp., a company that spun out cancer research at Johns Hopkins University and maintains a presence in Baltimore, raised $257 million in Series B funding, the company announced Wednesday. It’s the second nine-figure... |
| 29.07.2020 | Thrive Earlier Detection Raises $257M In Series B | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care, today announced that it has raised $257 million in a S... |
| 29.07.2020 | Thrive Earlier Detection Raises $257M in Series B Financing | Thrive Earlier Detection Corp., a Cambridge, MA-based company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care, raised $257m in Series B financing. The round was led by Casdin Capit... |
| 29.07.2020 | Test results in hand, Thrive raises $257M to push liquid biopsy toward approval | News from @thrivedetect : Series B, new investors, and progress towards a breakthrough cancer detection blood test. |
| 20.06.2019 | Isilon co-founder Sujal Patel building mysterious biotech startup, backed by Andreessen Horowitz | Sujal Patel. (GeekWire File Photo) Sujal Patel has seen a world-changing trend coming before. In 2001, in his mid-20s, he founded data storage technology company Isilon Systems in Seattle, correctly anticipating a massive increase in unstru... |
| 31.05.2019 | Foursquare Buys Location Data Company Placed From Snap: Term Sheet | CHANGING LOCATION Good morning, Term Sheet readers — I’m back! Paid Content Securing the enterprise without boundaries From ExtraHop Foursquare plans to merge Placed with its own ad-effectiveness-measurement product and rebrand it as “Place... |
Show more